PubSummary | Revisiting the changes in the Banff Classification for antibody‐mediated rejection after kidney transplantation | One Lambda

Publication Summary By: Christopher Lawrence With the 2017 classification for kidney allograft pathology Banff may have taken a retrograde step in the identification and prognostication of antibody mediated rejection. This study highlights the over simplification of the diagnosis of ABMR leading to a group of patients with less good outcomes being reclassified as ‘no ABMR’. The authors propose new intermediate categories of ABMR to replace ‘suspicious for ABMR’ and to improve personalization of.